AzTrials
AzTrials

Pediatric Intensive CarePupillomètreNCT02847195

Pupillometry in Pediatric Intensive Care Unit (PICU)

A study testing pupillometry in people with Pediatric Intensive Care, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Assess the depth of sedation and analgesia in pediatric intensive care is critical to the management of intubated patients under mechanical ventilation. The responsiveness of the pupil is changed by the sedation and analgesia. Read more about this study

Who is it for?
Ages Up to 18 years
Conditions the study is for
Pediatric Intensive Care
What is being tested?
pupillometry
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteFrance
Study dates
2 Dec 2014to 2 Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • children (age < 18 years) hospitalized in PICU
  • sedated because they are receiving mechanical ventilation,
  • for whom parents (or their representatives) have given their oral consent after written information.

Who cannot join

  • children receiving curare drugs
  • with congenital or acquired neurological,
  • with ophthalmologic pathology
  • or who does not benefit from social insurance coverage.

Trial locations and contacts

1 site in 1 country.

France1 site
  • service de réanimation pédiatrique, Hôpital Femme Mère Enfant (HFME), Hospices Civils de Lyon, 59 Boulevard Pinel

    Bron, 69500

Other trials in France

About this study

Official title: Evaluation of Pupillometry to Assess Analgesia in Children Unable to Communicate Verbally in Pediatric Intensive Care Unit (PICU)

Assess the depth of sedation and analgesia in pediatric intensive care is critical to the management of intubated patients under mechanical ventilation. The responsiveness of the pupil is changed by the sedation and analgesia. Measuring the pupil diameter is proposed in anesthesia and intensive care to assess the quality of analgesia in adult population. Visually measuring the diameter of the pupil remains very imprecise, but this measure can be accurately and quickly performed thanks to portable devices called Pupillometers. Some devices including Algiscan® device (IdMed ) can measure in addition to the pupil diameter, the variation of pupil diameter, the latency of the pupillary reflex and the maximum speed of contraction. Pupillometry was tested in adult ICU patients, during painful and painless procedures [1]. In this study, pupillometry was more sensitive for detecting pain compared to the change in heart rate or bispectral index. The objective of this work is to perform measurements of pupil diameter during painful procedures (e.g. tracheal aspiration) in PICU. In parallel we will continue using the Comfort B-scale (has been validated for assessment of pain in children admitted to a pediatric intensive care unit [2-5] and compare the results of both types of assessment pain.

Being tested
pupillometry
Keywords
pediatric intensive care, pain assessment, tracheal aspiration, sedation, pupillometer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pupillometryDevice

    This is a safe and painless examination (the device is simply placed on the orbit of the eye). The optical pupillometer is cleaned by doctors before and after each use, using cleaning wipes containing antibacterial, antiviral and antifungal drugs; such wipes are already in use in the service for cleaning equipment.

Study groups in NCT02847195
Study groupRoleWhat they receive
pediatric intensive careExperimentalWhen aspiration is planned, pain assessment will be performed thrice : 3-5 minutes before aspiration, during aspiration, and 3-5 minutes after aspiration. Pain assessment will be performed with both methods: * COMFORT B scale (routinely performed by nurses, and lasts less than one minute) * Simultaneously pupillometry is assessed using the device (Neurolight) (one measurement per eye, this also lasts less than one minute) These measurements can occur at any time during stay in ICU, and can be repeated.
Receives: Device: pupillometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pupillary diameter

    Estimate the performances of the variation of the pupillary diameter to assess pain in children admitted in PICU in comparison to results from the COMFORT-B scale taken as reference.

    Pupillometry is assessed using a specific device the Neurolight™ (ID MED™, France), (diagnostic test under evaluation), and compared to pain assessment using the score Comfort B scale ( hetero score assessment of pain in children sedated routinely used in PICU to evaluate pain).

    Measured: Day 1

  2. Comfort B Score

    Estimate the performances of the variation of the pupillary diameter to assess pain in children admitted in PICU in comparison to results from the COMFORT-B scale taken as reference.

    Pupillometry is assessed using a specific device the Neurolight™ (ID MED™, France), (diagnostic test under evaluation), and compared to pain assessment using the score Comfort B scale ( hetero score assessment of pain in children sedated routinely used in PICU to evaluate pain).

    Measured: Day 1

Secondary outcomes (3)
  1. Latency time

    Latency time assessed by the video pupillometer

    Measured: Day 1

  2. pupil diameter variation

    Pupil diameter variation assessed by the video pupillometer

    Measured: Day 1

  3. diameter variation time

    Diameter variation time assessed by the video pupillometer

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2016 (estimated)
  2. Study start2 Dec 2014
  3. Primary completion2 Jul 2019
  4. Study completion2 Jul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02847195
Sponsor's protocol ID
69HCL15_0642
Other IDs
2013-A01600-45
Acronym
Pupillomètre
Status last verified
Mar 2020
First submitted
25 Jul 2016
Last updated
30 Mar 2020
Results posted
No
Data monitoring committee
No

Publications

  • Portefaix A, Rabilloud M, Baudin F, Dantony E, Ginhoux T, Kassai-Koupai B, Javouhey E, Bordet F. Pupillometry for pain assessment in noncommunicating children in the pediatric intensive care unit: a prospective accuracy study. Eur J Pediatr. 2026 May 2;185(5):334. doi: 10.1007/s00431-026-07004-3.

    PubMed 42068463

Questions about this trial

What is this clinical trial studying?

A study testing pupillometry in people with Pediatric Intensive Care, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pupillary diameter (time frame: Day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02847195, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in